PM360 2021 Trailblazer Awards Persistence/Adherence Program Silver Winner EMD Serono and MyHealthTeams

MyMSTeam Treatment & Adherence Resource Center (EMD Serono, MyHealthTeams)

Despite evidence that multiple sclerosis (MS) patients on disease-modifying therapies (DMTs) experience better outcomes, 35% to 40% of people diagnosed with MS are not on a DMT.

To address this gap, MyHealthTeams and EMD Serono created the “Treatment & Adherence Resource Center.” This social network for people with MS has 168,000+ registered members who share firsthand experiences with the disease and provide practical tips for managing symptoms and side effects.

The Resource Center is a place where people can find on-demand, actionable information. With many in-person appointments on pause throughout the pandemic, the website became increasingly valuable.

Featured articles within the MyMSTeam Treatment and Adherence Resource Center include critical facts and advice for patients and caregivers, without mention of specific drugs.

So far, the Resource Center has had 110,000 visits with readers spending an average of 4.5 minutes on each article.


You May Also Like

PM360 2021 Innovative Product Trial Landscape from H1

Trial Landscape H1 Rob Consalvo, Senior Director of Sales Engineering & Enablement More ...

PM360 2018 Innovative Strategy Resource Centers from MyHealthTeams

Resource Centers MyHealthTeams Eric Peacock, Co-Founder and CEO Knowledge gaps prevent patients from ...

ELITE 2019 Marketing Team Pfizer-BMS Alliance Payer Marketing Team

Pfizer-BMS Alliance Payer Marketing Team Pfizer and Bristol-Myers Squibb Agency Partner: Entrée Health Team ...